 |
|
Battling Diabetes with Beta Cells
September 03, 2008Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure -- based on advances in cell therapy -- may be within reach.
Prof. Shimon Efrat from TAU's Sackler Faculty of Medicine, whose research group is among world leaders in beta cell expansion, has developed a way to cultivate cells derived from insulin-producing beta cells from human tissue in the laboratory. It may be possible to implant these new healthy cells into patients with type 1 diabetes.
If successful, this method, which artificially replicates the insulin cells people need, could ensure that fewer people will die while waiting for a life-saving pancreas and kidney. Prof. Efrat's research paves the way for new and alternative forms of treatment in cases in which organ transplantation is not an option. And one day, the procedure may be as simple as a blood transfusion.
The Multiplication Effect
Type 1 diabetes, the most severe form of the condition, emerges as a chronic condition in childhood or early adulthood, when the body's immune system stops working properly and destroys the beta cells in the pancreas. Beta cells are needed to produce insulin, and a shortage of insulin inhibits the breakdown of food into energy. By the time a diagnosis is made, most beta cells are destroyed beyond repair. Injections of insulin can ease the symptoms, but some sufferers from the disease eventually require extreme measures, such as organ transplants, to stay alive.
"The shortage of organ donors makes the development of new cell sources for cell therapy critical," says Prof. Efrat. "Using beta cell expansion, we are able to grow a massive reserve of healthy cells that may be made to produce enough insulin to restore the function of the destroyed cells."
In contrast to previous research, which failed to multiply mouse beta cells in culture, Prof. Efrat's work has increased the number of human beta cells successfully. "In theory, cells from one donor can be multiplied thousands of times," says Prof. Efrat, explaining that the next hurdle will be to "convince" these beta cells to produce insulin in the human body. Another major hurdle he faces is to get a body's immune system to accept these new cells when transplanted. Human clinical trials, Prof. Efrat cautions, may not begin for another five years or more.
The research, published in the acclaimed journal Diabetes and featured in a report by the Juvenile Diabetes Research Foundation, was performed in collaboration with the graduate students Holger Russ and Yael Bar.
American Friends of Tel Aviv University
The Multiplication Effect
Type 1 diabetes, the most severe form of the condition, emerges as a chronic condition in childhood or early adulthood, when the body's immune system stops working properly and destroys the beta cells in the pancreas. Beta cells are needed to produce insulin, and a shortage of insulin inhibits the breakdown of food into energy. By the time a diagnosis is made, most beta cells are destroyed beyond repair. Injections of insulin can ease the symptoms, but some sufferers from the disease eventually require extreme measures, such as organ transplants, to stay alive.
"The shortage of organ donors makes the development of new cell sources for cell therapy critical," says Prof. Efrat. "Using beta cell expansion, we are able to grow a massive reserve of healthy cells that may be made to produce enough insulin to restore the function of the destroyed cells."
In contrast to previous research, which failed to multiply mouse beta cells in culture, Prof. Efrat's work has increased the number of human beta cells successfully. "In theory, cells from one donor can be multiplied thousands of times," says Prof. Efrat, explaining that the next hurdle will be to "convince" these beta cells to produce insulin in the human body. Another major hurdle he faces is to get a body's immune system to accept these new cells when transplanted. Human clinical trials, Prof. Efrat cautions, may not begin for another five years or more.
The research, published in the acclaimed journal Diabetes and featured in a report by the Juvenile Diabetes Research Foundation, was performed in collaboration with the graduate students Holger Russ and Yael Bar.
American Friends of Tel Aviv University
Beta Cells Current Events and Beta Cells News RSSResearchers discover mechanism of insulin production that can lead to better treatment for diabetes
How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities.
CHEO RI study uses sophisticated genetic engineering to improve insulin-producing beta cells
One of the biggest mysteries about diabetes is why specialized cells in the pancreas stop secreting insulin, which the body needs in order to store glucose from food.
Team reveals molecular mechanism underlying a form of diabetes
By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion.
Diabetes advance: Researchers find gene that causes resistance to insulin
A breakthrough by an international team of researchers in Canada, France, the UK and Denmark has uncovered a new gene that could lead to better treatment of type 2 diabetes, as well as a better understanding of how this widespread disease develops.
Exercise alone shown to improve insulin sensitivity in obese sedentary adolescents
A moderate aerobic exercise program, without weight loss, can improve insulin sensitivity in both lean and obese sedentary adolescents.
Taking the Needle's Sting Out of Diabetes
Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials.
UT Southwestern physicians bust myths about insulin
People diagnosed with type 2 diabetes often resist taking insulin because they fear gaining weight, developing low blood sugar and seeing their quality of life decline.
Noninsulin-producing alpha cells in the pancreas can be converted to insulin-producing beta cells
In findings that add to the prospects of regenerating insulin-producing cells in people with type 1 diabetes, researchers in Europe -- co-funded by the Juvenile Diabetes Research Foundation -- have shown that insulin-producing beta cells can be derived from non-insulin-producing cells in the pancreas.
MRI May Help Physicians Diagnose, Stage and Treat Diabetes
Noninvasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of diabetes, according to a study performed at Massachusetts General Hospital and Harvard Medical School in Boston, MA.
Stem cell research: From molecular physiology to therapeutic applications
Stem cell research promises remedies to many devastating diseases that are currently incurable, ranging from diabetes and Parkinson's disease to paralysis.
More Beta Cells Current Events and Beta Cells News Articles
 |
Pancreatic Beta Cell in Health and Disease by Susumu Seino (Author), Susumu Seino (Editor), Graeme Bell (Editor) The beta cells of the pancreatic islets of Langerhans are the only cells in the body that produce and secrete insulin. This metabolic hormone plays a central role in the maintenance of glucose homeostasis, regulating glucose uptake in muscle and adipose tissue as well as carbohydrate, fat, and protein metabolism in these tissues and the liver. This book provides a comprehensive up-to-date review of the beta cell in health and disease. Chapters address the architecture and pathology of normal and diabetic pancreatic islets; regulation of beta-cell proliferation and death; the potential of stem cells and extra-pancreatic tissues as beta-cell replacement therapies; insulin biosynthesis; regulation of insulin secretion including metabolic control, ion channels, gap junctions,... |
 |
Source Naturals Beta Glucan 1,3/1,6 250mg, 60 tablets by Source Naturals Dietary supplement. Purified Beta - 1,3/1,6 - Glucan. Beta-glucan is a complex polysaccharide composed of glucose molecules extracted and purified from the cell wall of common baker's yeast, Saccharomyces cerevisiae. Beta-glucan is used to maintain or stimulate the effectiveness of the immune system. Animal and human cell culture studies have shown that Beta-glucan can stimulate several aspects of immune function, such as phagocytosis and interleukin production. Source Naturals Beta-glucan uses a purification process that removes the mannoproteins and yeast residues that may reduce the effectiveness of Beta - Glucan (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease). Suitable for... |
 |
Portal Beta Design Protective Skin Decal Sticker for Samsung Propel SGH-A767 Cell Phone by MyGift This scatch resistant skin sticker helps to protect your Samsung Propel SGH-A767 while making an impression. Self-adhesive plastic-coated skins cover the front and back of the phone and are custom cut to perfectly fit the Samsung Propel SGH-A767. Skins are paper-thin so they do not add any bulk, easy to apply (no bubbles), durable and easily removable without any residue. This is a sticker-liked skin, DOES NOT cover the screen of your phone, it comes with a code to download the matching wallpaper as shown. (Note: Due to differences in monitors, color may vary from photo.) |
 |
Heart Failure Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough oxygenated blood to meet the needs of the body?s other organs. The heart keeps pumping, but not as efficiently as a healthy heart. Usually, the loss in the heart?s pumping action is a symptom of an underlying heart problem. Heart failure affects nearly 5 million US adults. It is on the rise with an estimated 400,000 to 700,000 new cases each year. This talk will focus on the causes, symptoms, diagnosis and treatments available for heart failure, including current research findings from Stanford. |
 |
Elastology Lotus Renewal Wash by Clientele Increase cell renewal as you suds away impurities. Contains a combination of Alpha & Beta Hydroxy Acids from natural plants and fruits to enhance natural turnover of cells for fresh radiant skin. This wash is excellent for men and women, all ages with any skin type. |
 |
No-xplode 1.81 Lbs 40 Servings BSN AVPT, Orange by BSN Directions While mixing N.O.-Xplode, do not shake - stir powder with utensil. Recommended Use to Assess Your Tolerance: As a dietary supplement, begin by consuming 1 scoop of N.O.-Xplode mixed with 5-6 oz of cold water. Vary the amount of water to achieve your desired flavor and sweetness level. Wait 30 minutes to assess your tolerance. If appropriate, after 30 minutes consume an additional 1 scoop mixed with 5-6 oz of cold water and assess your tolerance again. Recommended Use on Training Days: Once your tolerance has been assessed, mix 1-3 scoops with 5-18 oz of cold water and consume 30-45 minutes before training. Use approximately 5-6 oz of water per 1 scoop of powder. Again, vary the amount of water to achieve your desired flavor and sweetness level. To achieve maximize results take... |
 |
Islet Transplantation and Beta Cell Replacement Therapy by A.M. James Shapiro (Editor), James A.M. Shaw (Editor) Beta cell replacement through transplantation remains the only treatment option for Type 1 diabetes enabling restoration of near-physiological glucose levels without significant hypoglycemia. Outlining the most recent advances and research breakthroughs, this practical guide and reference work explores the impact of islet cell transplantation and brings together leading multidisciplinary proponents critical to future success in the field. Edited by a surgeon and an endocrinologist at the forefront of the technology, this volume considers challenges associated with this procedure including lack of sufficient donor organs and the side effects of immunosuppressive therapy, as well as the potential benefits for current and future patients. |
 |
Vitamin Shoppe - Beta 1 3 Glucans, 200 mg, 120 tablets by Vitamin Shoppe Each tablet contains 200 mg of Beta 1,3 Glucans (Saccharomyces cerevisiae) (yeast cell wall). |
 |
Source Naturals Beta Glucan 1,3/1,6 100 mg, 60 capsules by Source Naturals Dietary supplement. Purified Beta -1.3/1.6 - Glucan. Beta Glucan is a complex polysaccharide composed of glucose molecules extracted & purified from the cell wall of common baker's yeast, Saccharomyces cerevisiae. Beta glucan is used to maintain or stimulate the effectiveness of immune system. Animal & human cell culture studies have shown that beta glucan can stimulate several aspects of immune function, such as phagocytosis & interleukin production. Source Natural's Beta Glucan uses a purification process that removes the mannoproteins & yeast residues that may reduce the effectiveness of Beta Glucan. (These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease). Contains no dairy, egg, gluten, corn, soy or wheat.... |
|
FCT Cuts Costs of Cells in Beta Units.(Fuel Cell Technologies): An article from: Fuel Cell Technology News by Gale Reference Team (Author) This digital document is an article from Fuel Cell Technology News, published by Thomson Gale on December 1, 2004. The length of the article is 590 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: FCT Cuts Costs of Cells in Beta Units.(Fuel Cell Technologies) Author: Gale Reference Team Publication: Fuel Cell Technology News (Newsletter) Date: December 1, 2004 Publisher: Thomson Gale Volume: 7 Issue: 3 Page: NA Distributed by Thomson... |
| © 2009 BrightSurf.com |